
Revance Therapeutics (RVNC)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Revance Therapeutics (RVNC) Stock
Start investing in Revance Therapeutics (RVNC)
About Revance Therapeutics (RVNC)
Market cap | $381.02M |
Today's volume | — |
Revenue (TTM) | $247M |
Avg. daily volume | 2.65M |
EBITDA (TTM) | -$159.93M |
Open | — |
Price / earnings ratio | -1.90x |
Today's range | — |
Debt / equity | — |
52 week range | $2.3 - $7.56 |
5 year debt / equity | 874.07x |
Beta (LTM) | 1.38x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 4.12x |
Ex-dividend date | — |
Next earnings | Apr 29, 2025 |
Dividend payable date | — |
Revance Therapeutics Stock Rating
Revance Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy RVNC stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in RVNC stock
Navigate to the Explore page. Then, type RVNC into the search bar. When you see RVNC stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased RVNC stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Revance Therapeutics Stock Earnings
The value each RVNC share was expected to gain vs. the value that each RVNC share actually gained.
Revance Therapeutics (RVNC) reported Q3 2024 earnings per share (EPS) of -$0.37, beating estimates of -$0.38 by 2.63%. In the same quarter last year, Revance Therapeutics's earnings per share (EPS) was -$0.55. Revance Therapeutics is expected to release next earnings on 04/29/2025, with an earnings per share (EPS) estimate of -$0.31.